Cargando…

Autoantibody Profiles in Autoimmune Rheumatic Diseases

A paradigmatic feature of autoimmune rheumatic diseases (ARD) is the presence of multiple autoantibodies. The use of antibody profiles in the study of ARD therefore should be the best strategy for both diagnostic and classification purposes. To this end, systems using micronized components (protein...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bizzaro, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2019
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045966/ https://www.ncbi.nlm.nih.gov/pubmed/32185346 http://dx.doi.org/10.31138/mjr.30.2.86

Ejemplares similares

Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010)

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
por: Di Lorenzo, Rosaria, et al.
Publicado: (2010)

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg, Judith LZ, et al.
Publicado: (2011)

National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
por: Nicastri, Emanuele, et al.
Publicado: (2020)

Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations
por: Baharudin, Abdullah, et al.
Publicado: (2019)

Degos disease – malignant atrophic papulosis or cutaneointestinal lethal syndrome: rarity of the disease
por: Pirolla, Eduardo, et al.
Publicado: (2015)

Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
por: Namas, Rajaie, et al.
Publicado: (2023)

A disease with many faces
por: Caires, Nídia, et al.
Publicado: (2019)

Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Betahistine in the treatment of Ménière’s disease
por: Lacour, Michel, et al.
Publicado: (2007)

An unusual disease with an interesting sign
por: Afthinos, Andreas, et al.
Publicado: (2020)

Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women
por: Genazzani, Andrea Riccardo, et al.
Publicado: (2006)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Continuous levodopa for advanced Parkinson’s disease
por: Lundqvist, Christofer
Publicado: (2007)

Update on ropinirole in the treatment of Parkinson’s disease
por: Shill, Holly A, et al.
Publicado: (2009)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Beta-amyloidolysis and glutathione in Alzheimer’s disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2013)

Assembly 12: interstitial lung diseases
por: Antoniou, Katerina, et al.
Publicado: (2018)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Assembly 5: airway diseases: Meet the Assemblies
por: Spanevello, Antonio
Publicado: (2017)

Updates in pulmonary hypertension and other pulmonary vascular diseases
por: Bernardo, Roberto J., et al.
Publicado: (2019)

Alzheimer’s Disease – Why We Need Early Diagnosis
por: Rasmussen, Jill, et al.
Publicado: (2019)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

An unusual presentation of a more common disease entity
por: Van de Kerkhove, Charlotte, et al.
Publicado: (2018)

Choosing pharmacotherapy for ILD in patients with connective tissue disease
por: Wu, Zhe, et al.
Publicado: (2021)

A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
por: Rodriguez-Garcia, Alejandro, et al.
Publicado: (2022)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019)

Clues beyond the lung: an unusual diagnosis in an infant with chronic lung disease
por: Walsh, Rachel, et al.
Publicado: (2020)

Contribution of causal factors to disease burden: how to interpret attributable fractions
por: Counil, Emilie
Publicado: (2021)

Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson’s disease
por: Cuomo, Arturo, et al.
Publicado: (2019)

How to carry out a field walking test in chronic respiratory disease
por: Holland, Anne E., et al.
Publicado: (2015)

A 43-year-old patient presenting with marked eosinophilia and multisystem disease
por: Panjwani, Amit, et al.
Publicado: (2016)

Egyptian Consensus on the Role of Lung Ultrasonography During the Coronavirus Disease 2019 Pandemic
por: Zaky, Samy, et al.
Publicado: (2022)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson’s disease: implications for patients
por: Antonini, Angelo, et al.
Publicado: (2011)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People’s Republic of China
por: Cai, Bai-qiang, et al.
Publicado: (2014)

Landmark papers in respiratory medicine: Automatic quantification of emphysema and airways disease on computed tomography
por: Mohamed Hoesein, Firdaus A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1vqjqngo0q4iclu8klp5vokr5o